MJA InSight ARTICLE

​

Triple drug therapy for newly diagnosed myeloma – when is more, better?

Authored by: Professor H. Miles Prince AM, Director of Cancer Immunology & Molecular Oncology, Epworth Healthcare

​

​

​

​

​

​

​